Christopher Baccei

1.0k total citations
24 papers, 816 citations indexed

About

Christopher Baccei is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Christopher Baccei has authored 24 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Physiology and 8 papers in Pharmacology. Recurrent topics in Christopher Baccei's work include Asthma and respiratory diseases (9 papers), Receptor Mechanisms and Signaling (7 papers) and Inflammatory mediators and NSAID effects (6 papers). Christopher Baccei is often cited by papers focused on Asthma and respiratory diseases (9 papers), Receptor Mechanisms and Signaling (7 papers) and Inflammatory mediators and NSAID effects (6 papers). Christopher Baccei collaborates with scholars based in United States, Switzerland and Canada. Christopher Baccei's co-authors include Daniel S. Lorrain, Linda J. Bristow, Mark A. Varney, Lucia Correa, Peppi Prasit, Nicholas Stock, John H. Hutchinson, Angelina M. Santini, Gretchen Bain and Jilly F. Evans and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Neuroscience.

In The Last Decade

Christopher Baccei

24 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Baccei United States	14	411	307	242	148	139	24	816
Masakuni Horiguchi Japan	14	382 0.9×	389 1.3×	101 0.4×	82 0.6×	35 0.3×	16	757
Lucia Correa United States	17	239 0.6×	523 1.7×	165 0.7×	31 0.2×	193 1.4×	29	839
Adrienne Müller Herde Switzerland	19	299 0.7×	231 0.8×	178 0.7×	54 0.4×	60 0.4×	32	653
Francisco R. Lopez‐Picon Finland	18	340 0.8×	283 0.9×	117 0.5×	63 0.4×	302 2.2×	47	904
Lucia Frau Italy	17	482 1.2×	285 0.9×	127 0.5×	29 0.2×	113 0.8×	34	1.1k
Maria Antonietta Stasi Italy	16	351 0.9×	361 1.2×	65 0.3×	38 0.3×	65 0.5×	31	814
Patrick N. McCormick Canada	15	515 1.3×	418 1.4×	63 0.3×	70 0.5×	77 0.6×	22	978
Meaghan Morris United States	9	402 1.0×	564 1.8×	184 0.8×	35 0.2×	809 5.8×	18	1.4k
Shang‐Yi Tsai United States	17	588 1.4×	1.1k 3.6×	206 0.9×	260 1.8×	93 0.7×	26	1.4k
Giulia Ambrosi Italy	17	294 0.7×	347 1.1×	75 0.3×	24 0.2×	175 1.3×	26	941

Countries citing papers authored by Christopher Baccei

Since Specialization

Citations

This map shows the geographic impact of Christopher Baccei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Baccei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Baccei more than expected).

Fields of papers citing papers by Christopher Baccei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Baccei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Baccei. The network helps show where Christopher Baccei may publish in the future.

Co-authorship network of co-authors of Christopher Baccei

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Baccei. A scholar is included among the top collaborators of Christopher Baccei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Baccei. Christopher Baccei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poon, Michael M., Karin J. Stebbins, Christopher Baccei, et al.. (2024). Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis. Scientific Reports. 14(1). 10573–10573. 3 indexed citations

Stebbins, Karin J., Jeffrey Roppe, Christopher Baccei, et al.. (2024). Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis. Proceedings of the National Academy of Sciences. 121(32). e2407974121–e2407974121. 14 indexed citations

Schrader, Thomas O., Didier Bagnol, Christopher Baccei, et al.. (2024). Identification and In Vivo Evaluation of Myelination Agent PIPE-3297, a Selective Kappa Opioid Receptor Agonist Devoid of β-Arrestin-2 Recruitment Efficacy. ACS Chemical Neuroscience. 15(3). 685–698. 3 indexed citations

Jacintho, Jason, Christopher Baccei, Austin Chen, et al.. (2018). Discovery of potent and selective PPARα/δ dual antagonists and initial biological studies. Bioorganic & Medicinal Chemistry Letters. 29(3). 503–508. 7 indexed citations

Stebbins, Karin J., Lucia Correa, Davorka Messmer, et al.. (2017). In vitro and in vivo pharmacology of NXT629, a novel and selective PPARα antagonist. European Journal of Pharmacology. 809. 130–140. 25 indexed citations

Masoodi, Mojgan, Michael Eiden, Yuankai Shi, et al.. (2014). A role for oleoylethanolamide in chronic lymphocytic leukemia. Leukemia. 28(7). 1381–1387. 24 indexed citations

Baccei, Christopher, Richard A. Bundey, Austin Chen, et al.. (2014). Identification of the first potent, selective and bioavailable PPARα antagonist. Bioorganic & Medicinal Chemistry Letters. 24(10). 2267–2272. 9 indexed citations

Stock, Nicholas, Gretchen Bain, Yiwei Li, et al.. (2011). 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3- tert -Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1 H -indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor. Journal of Medicinal Chemistry. 54(23). 8013–8029. 39 indexed citations

Baccei, Christopher, Gretchen Bain, Jilly F. Evans, et al.. (2011). Discovery and optimization of a biphenylacetic acid series of prostaglandin D2 receptor DP2 antagonists with efficacy in a murine model of allergic rhinitis. Bioorganic & Medicinal Chemistry Letters. 21(21). 6608–6612. 3 indexed citations

10.

Bain, Gretchen, Daniel S. Lorrain, Karin J. Stebbins, et al.. (2011). Pharmacology of AM211, a Potent and Selective Prostaglandin D2 Receptor Type 2 Antagonist That Is Active in Animal Models of Allergic Inflammation. Journal of Pharmacology and Experimental Therapeutics. 338(1). 290–301. 20 indexed citations

11.

Stock, Nicholas, Deborah L. Volkots, Karin J. Stebbins, et al.. (2010). Sodium [2′-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4′-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): A potent, selective prostaglandin D2 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 21(3). 1036–1040. 9 indexed citations

12.

Lorrain, Daniel S., Gretchen Bain, Lucia Correa, et al.. (2010). Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation. European Journal of Pharmacology. 640(1-3). 211–218. 19 indexed citations

13.

Stock, Nicholas, Christopher Baccei, Gretchen Bain, et al.. (2010). 5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-tert-Butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM643)—A potent FLAP inhibitor suitable for topical administration. Bioorganic & Medicinal Chemistry Letters. 20(15). 4598–4601. 12 indexed citations

14.

Lorrain, Daniel S., Gretchen Bain, Lucia Correa, et al.. (2009). Pharmacological Characterization of 3-[3-tert-Butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic Acid (AM103), a Novel Selective 5-Lipoxygenase-Activating Protein Inhibitor That Reduces Acute and Chronic Inflammation. Journal of Pharmacology and Experimental Therapeutics. 331(3). 1042–1050. 11 indexed citations

15.

Stearns, Brian A., Christopher Baccei, Gretchen Bain, et al.. (2009). Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitis. Bioorganic & Medicinal Chemistry Letters. 19(16). 4647–4651. 37 indexed citations

16.

Stock, Nicholas, Christopher Baccei, Gretchen Bain, et al.. (2009). 5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)—A potent FLAP inhibitor. Bioorganic & Medicinal Chemistry Letters. 20(1). 213–217. 20 indexed citations

17.

Stebbins, Karin J., Christopher Baccei, Heather Coate, et al.. (2009). Pharmacological Blockade of the DP2 Receptor Inhibits Cigarette Smoke-Induced Inflammation, Mucus Cell Metaplasia, and Epithelial Hyperplasia in the Mouse Lung. Journal of Pharmacology and Experimental Therapeutics. 332(3). 764–775. 40 indexed citations

18.

Lorrain, Daniel S., Christopher Baccei, Lucia Correa, & Linda J. Bristow. (2005). Comparison of the effects of diazepam, the CRF1 antagonist CP-154,526 and the group II mGlu receptor agonist LY379268 on stress-evoked extracellular norepinephrine levels. Neuropharmacology. 48(7). 927–935. 17 indexed citations

19.

Lorrain, Daniel S., Hervé Schaffhauser, Una C. Campbell, et al.. (2003). Group II mGlu Receptor Activation Suppresses Norepinephrine Release in the Ventral Hippocampus and Locomotor Responses to Acute Ketamine Challenge. Neuropsychopharmacology. 28(9). 1622–1632. 78 indexed citations

20.

Lorrain, Daniel S., et al.. (2003). Effects of ketamine and n-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience. 117(3). 697–706. 341 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact